U.S. flag

An official website of the United States government

NM_000162.5(GCK):c.579+29G>T AND not specified

Germline classification:
Benign (1 submission)
Last evaluated:
Nov 6, 2020
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV004017848.1

Allele description [Variation Report for NM_000162.5(GCK):c.579+29G>T]

NM_000162.5(GCK):c.579+29G>T

Gene:
GCK:glucokinase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
7p13
Genomic location:
Preferred name:
NM_000162.5(GCK):c.579+29G>T
HGVS:
  • NC_000007.14:g.44149940C>A
  • NG_008847.2:g.53231G>T
  • NM_000162.5:c.579+29G>TMANE SELECT
  • NM_001354800.1:c.579+29G>T
  • NM_033507.3:c.582+29G>T
  • NM_033508.3:c.576+29G>T
  • LRG_1074t1:c.579+29G>T
  • LRG_1074t2:c.582+29G>T
  • LRG_1074:g.53231G>T
  • NC_000007.13:g.44189539C>A
Links:
dbSNP: rs35786405
NCBI 1000 Genomes Browser:
rs35786405
Molecular consequence:
  • NM_000162.5:c.579+29G>T - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001354800.1:c.579+29G>T - intron variant - [Sequence Ontology: SO:0001627]
  • NM_033507.3:c.582+29G>T - intron variant - [Sequence Ontology: SO:0001627]
  • NM_033508.3:c.576+29G>T - intron variant - [Sequence Ontology: SO:0001627]

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Help
Submission AccessionSubmitterReview Status
(Assertion method)		Clinical Significance
(Last evaluated)		OriginMethodCitations
SCV004848493Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
criteria provided, single submitter

(ACMG Guidelines, 2015)		Benign
(Nov 6, 2020) 		germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine, SCV004848493.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

The c.576+29G>T variant in GCK classified as benign because it has been identified in 1.7% (332/19950) of East Asian chromosomes, including 1 homozygote occurence, by gnomAD (http://gnomad.broadinstitute.org). In additon, it is not located within the splice consensus sequence and computational splice prediction tools do not predict an effect on splice. ACMG/AMP Criteria applied: BA1, BP4, BP7.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 1, 2024